Ceftazidime/avibactam
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Southern California
Overview
Ceftazidime/avibactam is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Ceftazidime/avibactam clinical trials
Explore related
Medical disclaimer. This page summarizes research about Ceftazidime/avibactam for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.